中国药师
中國藥師
중국약사
CHINA PHARMACIST
2015年
1期
52-54,55
,共4页
裴德宁%郭莹%李永红%韩春梅%丁有学%李响%饶春明
裴德寧%郭瑩%李永紅%韓春梅%丁有學%李響%饒春明
배덕저%곽형%리영홍%한춘매%정유학%리향%요춘명
重组人干扰素α2a%评价性抽验%质量分析
重組人榦擾素α2a%評價性抽驗%質量分析
중조인간우소α2a%평개성추험%질량분석
Recombinant human interferon α2a%Evaluative sampling%Quality evaluation
目的::评价国产重组人干扰素α2a注射剂的质量现状及存在问题。方法:采用法定检验方法结合探索性研究进行样品检验,统计分析检验结果,对国产重组人干扰素α2a注射剂的质量现状进行评价。结果:法定检验显示28批成品全部合格,7批原液全部合格(部分检验)。探索性研究显示若在成品中增加比活性测定,则合格率为87.0%,若在原液中增加相关蛋白含量测定,则合格率为57.1%。结论:该品种总体质量状况良好,现行检验标准基本可行,但有待提高,建议在成品中增加比活性检测,在原液中增加相关蛋白含量检测。
目的::評價國產重組人榦擾素α2a註射劑的質量現狀及存在問題。方法:採用法定檢驗方法結閤探索性研究進行樣品檢驗,統計分析檢驗結果,對國產重組人榦擾素α2a註射劑的質量現狀進行評價。結果:法定檢驗顯示28批成品全部閤格,7批原液全部閤格(部分檢驗)。探索性研究顯示若在成品中增加比活性測定,則閤格率為87.0%,若在原液中增加相關蛋白含量測定,則閤格率為57.1%。結論:該品種總體質量狀況良好,現行檢驗標準基本可行,但有待提高,建議在成品中增加比活性檢測,在原液中增加相關蛋白含量檢測。
목적::평개국산중조인간우소α2a주사제적질량현상급존재문제。방법:채용법정검험방법결합탐색성연구진행양품검험,통계분석검험결과,대국산중조인간우소α2a주사제적질량현상진행평개。결과:법정검험현시28비성품전부합격,7비원액전부합격(부분검험)。탐색성연구현시약재성품중증가비활성측정,칙합격솔위87.0%,약재원액중증가상관단백함량측정,칙합격솔위57.1%。결론:해품충총체질량상황량호,현행검험표준기본가행,단유대제고,건의재성품중증가비활성검측,재원액중증가상관단백함량검측。
Objective: To evaluate the quality status of recombinant human interferon α2a injections and find out some quality problems. Methods:The statutory testing methods combining with the exploratory studies were used to examine the samples, and the quality status of recombinant human interferon α2a injections was evaluated by statistical analysis of the results. Results: All 28 bat-ches of the injections were qualified using the statutory testing methods. The exploratory studies showed that if the specific activity was determined, the qualified rate was only 87. 0%. All 7 batches of drug substances were qualified using the statutory testing methods. The exploratory studies showed that if the related protein was determined, the qualified rate was 57. 1%. Conclusion:At present the quality of recombinant human interferonα2a injections is generally good. The current standards are feasible;however, improvement is still needed. Specific activity determination should be supplemented the standards for drug products and related protein determination should be supplemented the standards of drug substances.